To accelerate breakthroughs in research to develop treatments and a cure for CASK gene disorders.
Main program · fiscal year 2024
To fund basic and translational research to develop treatments for CASK gene disorders and to educate families affected by CASK gene disorders on the development of treatments for CASK gene disorders.$12,457 spent
Where each dollar went · fiscal year 2024
Of every dollar it spent, 75¢ went to programs, 25¢ to management and 0¢ to fundraising.
Programs $12,457
Management $4,196
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$206,513Fiscal year 2024
Expenses$16,653Fiscal year 2024
Total assets$274,947Fiscal year 2024
Total liabilities$0Fiscal year 2024
Fiscal year ending December2024
Revenue$206,513
Expenses$16,653
Net income$189,860
Net assets$274,947
Notable sources of revenue
Percent of total revenue
Contributions
$206,896
100.2%
Program services
$0
0.0%
Investment income
$7
0.0%
Other (net)
−$390
−0.2%
Assets / debt
Total assets
$274,947
Total liabilities
$0
Net assets
$274,947
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?